Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 39,316,911	$ 51,674,087
Other receivables	1,729,851	1,145,317
Prepaid expenses	6,770,426	2,476,612
Total current assets	47,817,188	55,296,016
Property and equipment, net	25,366	26,041
Other non-current assets	1,344,028	485,120
Total assets	49,186,582	55,807,177
Current liabilities
Accounts payable	2,830,866	2,103,083
Accrued expenses	3,537,856	3,136,244
Deferred grant funding	9,731,363	10,542,983
Current portion of lease liabilities	294,474	270,546
Total current liabilities	16,394,559	16,052,856
Deferred license revenue	1,000,000	1,000,000
Lease liabilities long-term	913,113	0
Total liabilities	18,307,672	17,052,856
Commitments and contingencies (Note 7)
Stockholders' equity
Preferred stock, $0.01 par value, 5,000,000 shares authorized; None issued and outstanding	0	0
Common stock, $0.0001 par value; 120,000,000 shares authorized; 83,944,119 shares issued and outstanding at March 31, 2022 and December 31, 2021	8,394	8,394
Accumulated other comprehensive loss	(164,123)	(154,973)
Additional paid-in capital	149,560,211	149,027,802
Accumulated deficit	(118,525,572)	(110,126,902)
Total stockholders' equity	30,878,910	38,754,321
Total liabilities and stockholders' equity	$ 49,186,582	$ 55,807,177

Deferred Grant Funding Current

No definition available.

Name:	dare_DeferredGrantFundingCurrent
Namespace Prefix:	dare_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).